Illumination of a Vision 2020-Urinary Based Biomarkers for Bladder Cancer on the Way to Clinical Decisions-Dream or Nightmare?

被引：2

作者：

Ecke, Thorsten H. ^{[1
]}

Otto, Thomas ^{[2
,3
]}

机构：

[1] HELIOS Hosp Bad Saarow, Dept Urol, D-15526 Bad Saarow Pieskow, Germany

[2] Lukaskrankenhaus Neuss, Dept Urol, D-41464 Neuss, Germany

[3] Univ Hosp Essen, D-45147 Essen, Germany

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2020年 / 21卷 / 05期

关键词：

UROTHELIAL CARCINOMA; CELL-CARCINOMA; PATHWAYS; FGFR3; MANAGEMENT; MUTATIONS; MARKERS;

D O I：

10.3390/ijms21051694

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页数：3

共 22 条

[1] Considerations on the use of diagnostic markers in management of patients with bladder cancer [J].

Agarwal, Piyush K. ;

Black, Peter C. ;

Kamat, Ashish M. .

WORLD JOURNAL OF UROLOGY, 2008, 26 (01) :39-44

[2] EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016 [J].

Babjuk, Marko ;

Boehle, Andreas ;

Burger, Maximilian ;

Capoun, Otakar ;

Cohen, Daniel ;

Comperat, Eva M. ;

Hernandez, Virginia ;

Kaasinen, Eero ;

Palou, Joan ;

Roupret, Morgan ;

van Rhijn, Bas W. G. ;

Shariat, Shahrokh F. ;

Soukup, Viktor ;

Sylvester, Richard J. ;

Zigeuner, Richard .

EUROPEAN UROLOGY, 2017, 71 (03) :447-461

[3]

Bakkar AA, 2003, CANCER RES, V63, P8108

[4]

Barkan GA, 2016, ADV ANAT PATHOL, V23, P193, DOI 10.1016/j.jasc.2016.04.005

[5] Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study [J].

Batista, Rui ;

Vinagre, Joao ;

Prazeres, Hugo ;

Sampaio, Cristina ;

Peralta, Pedro ;

Conceicao, Paulo ;

Sismeiro, Amlcar ;

Leao, Ricardo ;

Gomes, Andreia ;

Furriel, Frederico ;

Oliveira, Carlos ;

Torres, Joao Nuno ;

Eufrasio, Pedro ;

Azinhais, Paulo ;

Almeida, Fabio ;

Romero Gonzalez, Edwin ;

Bidovanets, Bohdan ;

Ecke, Thorsten ;

Stinjs, Pascal ;

Serrano Pascual, Alvaro ;

Abdelmalek, Rabehi ;

Villafruela, Ainara ;

Beardo-Villar, Pastora ;

Fidalgo, Nuno ;

Ozturk, Hakan ;

Gonzalez-Enguita, Carmen ;

Monzo, Juan ;

Lopes, Tome ;

Alvarez-Maestro, Mario ;

Parra Servan, Patricia ;

Perez De La Cruz, Santiago Moreno ;

Sanchez Perez, Mario Pual ;

Maximo, Valdemar ;

Soares, Paula .

FRONTIERS IN GENETICS, 2019, 10

[6] The health economics of bladder cancer - A comprehensive review of the published literature [J].

Botteman, MF ;

Pashos, CL ;

Redaelli, A ;

Laskin, B ;

Hauser, R .

PHARMACOECONOMICS, 2003, 21 (18) :1315-1330

[7] UBC® Rapid Test-A Urinary Point-of-Care (POC) Assay for Diagnosis of Bladder Cancer with a focus on Non-Muscle Invasive High-Grade Tumors: Results of a Multicenter-Study [J].

Ecke, Thorsten H. ;

Weiss, Sarah ;

Stephan, Carsten ;

Hallmann, Steffen ;

Arndt, Christian ;

Barski, Dimitri ;

Otto, Thomas ;

Gerullis, Holger .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (12)

[8] Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 [J].

Ferlay, J. ;

Steliarova-Foucher, E. ;

Lortet-Tieulent, J. ;

Rosso, S. ;

Coebergh, J. W. W. ;

Comber, H. ;

Forman, D. ;

Bray, F. .

EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) :1374-1403

[9]

Guo Aiye, 2014, Can Urol Assoc J, V8, pE347, DOI 10.5489/cuaj.1668

[10] FGFR3 and Tp53 mutations in T1G3 transitional bladder carcinomas:: Independent distribution and lack of association with prognosis [J].

Hernández, S ;

López-Knowles, E ;

Lloreta, J ;

Kogevinas, M ;

Jaramillo, R ;

Amorós, A ;

Tardón, A ;

García-Closas, R ;

Serra, C ;

Carrato, A ;

Malats, N ;

Real, FX .

CLINICAL CANCER RESEARCH, 2005, 11 (15) :5444-5450

← 1 2 3 →